Viewing Study NCT00111618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:02 AM
Ignite Modification Date: 2026-01-21 @ 10:40 PM
Study NCT ID: NCT00111618
Status: COMPLETED
Last Update Posted: 2009-01-30
First Post: 2005-05-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
Sponsor: Antisoma Research
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vascular disrupting agent View
None safety View
None tolerability View
None efficacy View
None hormone refractory prostate cancer View